146 Identifying niches of tissue resident immunological memory that underlie psoriasis relapse after treatment with ustekinumab

Dan Joseph Stein; Hyun-Sun Lee; Jessica E. Teague; Kevin Wei; Dawn E. Smilek; James M. Krueger; Laura G. Cooney; Rachael Clark; Ilya Korsunsky

doi:10.1016/j.jid.2025.09.161

Related publications

Article2022

Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment

Angela Pizzolla, Simon P. Keam, Ismael A. Vergara, Franco Caramia, Niko Thio, Minyu Wang, Nikolce Kocovski, Daniela Tantalo, Jafar S. Jabbari, George Au‐Yeung, Shahneen Sandhu, David Gyorki, Alison M. Weppler, Maurizio Perdicchio, Grant A. McArthur, Anthony T. Papenfuss, Paul J. Neeson

Article2020

548 CD8+ tissue-resident memory T cells are tumour reactive and increase after immunotherapy in a case of metastatic mucosal melanoma

Angela Pizzolla, Simon P. Keam, Ismael A. Vergara, Franco Caramia, Minyu Wang, Nikolce Kocovski, ThuNgoc Nguyen, Sean Macdonald, Daniela Tantalo, Pasquale Petrone, Han Xian Aw Yeang, David Gyorki, Alison M. Weppler, George Au‐Yeung, Shahneen Sandhu, Maurizio Perdicchio, Grant A. McArthur, Anthony T. Papenfuss, Paul J. Neeson

Article2019

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis

Teresa Tsakok, Nina Wilson, Nick Dand, Floris C. Loeff, Karien Bloem, David Baudry, Michael Duckworth, Shan Pan, Angela Pushpa‐Rajah, Joseph F. Standing, Annick de Vries, Ali Alsharqi, G Becher, Ruth Murphy, Shyamal Wahie, Andrew Wright, Christopher Em Griffiths, Nick J. Reynolds, Juliet N. Barker, Richard B. Warren, A. David Burden, Theo Rispens, Deborah Stocken, Catherine Smith

Article2014

Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: results from the <scp>CRYSTEL</scp> study

Christopher Em Griffiths, Thomas A. Luger, Y. Brault, Jean‐Michel Germain, Lotus Mallbris

Article2022

Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis

Zenas Z N Yiu, G Becher, Brian Kirby, Philip Laws, Nick J. Reynolds, Catherine Smith, Richard B. Warren, Christopher Em Griffiths, Fiona Browne, Ian Evans, Elise Kleyn, Linda Lawson, Kathleen McElhone, Teena Mackenzie, Tess McPherson, Ruth Murphy, Caroline Owen, Eleanor Pearson, Josh Richards, Mark Lunt, A. David Burden, Oras Alabas,